Patricia Guerrero-Ochoa

Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment

J. Raso, A. Anel, R. Hurtado-Guerrero, 2022, Biomedicines.

The demand for a COVID-19 vaccine in Ecuador

D. Hudson, Carlos E. Carpio, Patricia Guerrero-Ochoa, 2020, Vaccine.

Antibody-Based Immunotoxins for Colorectal Cancer Therapy

A. Anel, L. Sanz, J. Lacadena, 2021, Biomedicines.

Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin

A. Anel, L. Sanz, B. Conde, 2019, Oncoimmunology.

In vivo potential of recombinant granulysin against human melanoma.

A. Anel, B. Conde, L. Martínez-Lostao, 2021, Cancer treatment and research communications.

Production of a Granulysin-Based, Tn-Targeted Cytolytic Immunotoxin Using Pulsed Electric Field Technology

J. Raso, A. Anel, Diederich Aguilar-Machado, 2020, International journal of molecular sciences.

Conjugation of the 9-kDa Isoform of Granulysin with Liposomes Potentiates Its Cytotoxicity

A. Anel, I. Marzo, J. Marco-Brualla, 2022, International journal of molecular sciences.

Prostate Cancer and the Mevalonate Pathway

Patricia Guerrero-Ochoa, L. M. Esteban, Sergio Rodríguez-Zapater, 2024, International journal of molecular sciences.